Lymphocytotoxic antibodies. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Lymphocytotoxic antibodies.

In Vivo. 1988 Jan-Feb;2(1):67-71. Unique Identifier : AIDSLINE MED/92135557
DeHoratius RJ; Division of Clinical Immunology/Rheumatology, Hahnemann; University, Philadelphia, PA 19102.

Abstract: LCTA are a heterogenous group of antibodies found in many disease states. The recurring observation is that they are able to modulate immune function in vitro. The exact mechanism of this modulation is unknown, however, alteration of cell surface antigens appears to be important. Recent advances in molecular biological techniques have made the surface antigen, against which LCTA is directed, more accessible. Once the surface antigen is identified, the exact role of LCTA may then be elucidated. Endothelial cell damage is a recurring pathologic finding in many of the diseases discussed. Again, identification of the antigen and its similarity to antigens on various cell types may help explain the immunopathogenesis of the different disease processes.
Keywords: Acquired Immunodeficiency Syndrome/IMMUNOLOGY Antilymphocyte Serum/*ANALYSIS Autoimmune Diseases/*IMMUNOLOGY Connective Tissue Diseases/IMMUNOLOGY Human Lupus Erythematosus, Systemic/GENETICS/*IMMUNOLOGY JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL

KWDacquiredimmunodeficiencysyndrome/immunologyantilymphocyteserum/KWDanalysisautoimmunediseases/KWDimmunologyconnectivetissuediseases/immunologyhumanlupuserythematosus,systemic/genetics/KWDimmunologyjournalarticlereviewreview,tutorial
920530
M9250947

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .